Progyny, Inc. (PGNY): Cost of Revenue
$984.18M
Year ended 2025-12-31
$988.68M
Trailing 12 months to 2026-06-30
+16.7%
3-year compound annual growth
+29.1%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $984.18M | +7.7% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $913.86M | +7.5% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $849.80M | +37.2% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $619.59M | +59.5% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $388.49M | +41.4% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $274.80M | +49.2% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $184.18M | +114.2% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $85.97M | +108.7% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $41.18M | n/a | 2020-03-10, From 2017-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Progyny, Inc. (PGNY) | 2025-12-31 | $984.18M | +7.7% |
| Sotera Health Co (SHC) | 2025-12-31 | $518.08M | +4.0% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $114.82M | +26.1% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $7.38M | -7.2% |
| Charming Medical Ltd (MCTA) | 2026-03-31 | $35.2K | +127.0% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $54.4K | -41.7% |
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $23.8K | -15.1% |
Compare PGNY, SHC, VMD, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗